DBV Technologies | DBVT - EPS Earnings Per Share

Stock Price
23.37
Daily Change
0.87 3.87%
Monthly
37.55%
Yearly
410.26%
Q1 Forecast
21.05

DBV Technologies reported $-0.24 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.





Eps Change Date
Acadia Pharmaceuticals USD 0.42 0.26 Sep/2025
Alnylam Pharmaceuticals USD 2.9 2.58 Sep/2025
Amarin USD 0.08 0.11 Sep/2025
BioMarin Pharmaceutical USD 0.12 1.32 Sep/2025
DBV Technologies USD -0.24 1.31 Sep/2025
Halozyme Therapeutics USD 1.72 0.18 Sep/2025
Incyte USD 2.26 0.69 Sep/2025
Insmed USD -1.75 0.05 Sep/2025
Ionis Pharmaceuticals USD -0.8 1.5 Sep/2025
Neurocrine Biosciences USD 2.17 0.52 Sep/2025
PTC Therapeutics USD 0.2 1.03 Sep/2025
Sarepta Therapeutics USD -0.13 2.15 Sep/2025
Ultragenyx Pharmaceutical USD -1.81 0.64 Sep/2025
United Therapeutics USD 7.16 0.75 Sep/2025